Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation

Bone Marrow Transplantation

Volumn 27, Issue 5, 2001, Pages 499-505

  ozcan M ^a   Ustun C ^a   Akcaglayan E ^a   Akan, H ^a   Arslan, o ^a   Ilhan, O ^a   Beksac M ^a   Gurman G ^a   Demirer, T ^a   Arat, M ^a   Celebi H ^a   Konuk, N ^a   Uysal, A ^a   Koc H ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Allogeneic PBSC transplantation; G CSF; GVHD

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; BUSULFAN; CARBAPENEM; CEPHALOSPORIN; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; LYMPHOCYTE ANTIBODY; METHOTREXATE; METHYLPREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY; VANCOMYCIN;

ACUTE DISEASE; ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; INCIDENCE; LEUKEMIA; LEUKOCYTE COUNT; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SIBLING; THROMBOCYTE COUNT; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOLOGIC NEOPLASMS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; INFECTION; MALE; MIDDLE AGED; NUCLEAR FAMILY; RECURRENCE; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 17744394479     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702816     Document Type: Article

References (37)

1. Recombinant human granulocyte-macrophage colony-stimulating factor in allogeneic bone marrow transplantation
2. Randomised vehicle controlled dose finding study of glycosylated recombinant human granulocyte-colony stimulating factor after bone marrow transplantation
3. Phase I/II trial of recombinant granulocyte-macrophage colony stimulating factor following allogeneic bone marrow transplantation
4. Human recombinant GM-CSF in allogeneic bone marrow transplant for leukemia: Double blind placebo controlled trial
5. Recombinant human granulocyte-colony stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation
6. Phase III double blind trial of rhGM-CSF following bone marrow transplant
7. Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation
8. G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: Results of a randomised BNLI trial
9. Filgrastim fails to improve hematopoietic reconstitution following myeloablative chemotherapy and peripheral blood stem cell rescue
10. Randomized study of growth factors post-peripheral-stem-cell transplant: Neutrophil recovery is improved with modest clinical benefit
11. Hematopoietic recovery after peripheral blood progenitor cell transplantation
12. Blood and bone marrow transplantation activity in Europe
13. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation
14. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: A focus on the incidence of graft versus host disease and relapse
15. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts
16. The evaluation of clinical peripheral blood stem cell transplantation
17. Allogeneic blood cell transplantation for hematologic malignancy: Preliminary comparison of outcome with bone marrow transplantation
18. Allogeneic blood cell transplantation without posttransplant colony-stimulating factors in patients with hematopoietic neoplasm: A phase II study
19. Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies
20. Allogeneic peripheral blood stem cell transplantation with advanced hematologic malignancies: A retrospective comparison with marrow transplantation
21. Consensus conference on acute GVHD grading
22. Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors
23. A controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation
24. High incidence of chronic graft versus host disease (GVHD) after allogeneic blood progenitor cell transplantation (allo-PBSCT) from matched related donors
25. Peripheral blood stem cell transplantation from unrelated donors: A comparison with marrow transplantation
26. Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis - Are there new strategies?
27. Factors that influence collection and engraftment of autologous peripheral blood stem cells
28. Influence of recombinant human granulocyte colony-stimulating factor (filgastrim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors
29. Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation
30. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis
31. Phase III randomized, double-blind placebo-controlled rhGM-CSF following allogeneic bone marrow transplantation
32. Effect of granulocyte-macrophage colony stimulating factor on oral mucositis after hematopoietic stem cell transplantation
33. Allogeneic transplantation with blood stem cells mobilized by G-CSF for hematologic malignancies
34. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by Filgrastim (G-CSF)
35. Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donor, compared to bone marrow
36. Pretreatment of donor mice with granulocyte-colony stimulating factor polarizes T-lymphocytes towards type 2 cytokine production and reduced severity of experimental graft-versus-host disease
37. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus host disease